AAAAAA

   
Results: 1-12 |
Results: 12
ASSESSMENT OF EQUIVALENCE ON MULTIPLE END-POINTS
Authors: QUAN H BOLOGNESE J LONG JM YUAN WY
Citation: H. Quan et al., ASSESSMENT OF EQUIVALENCE ON MULTIPLE END-POINTS, Zhongguo yaoli xuebao, 19, 1998, pp. 27-28
INDIVIDUAL RADIOGRAPHIC FEATURES (IRFS) ARE NOT ASSOCIATED WITH SEVERITY OF PAIN AND PHYSICAL-DISABILITY IN PATIENTS WITH KNEE OSTEOARTHRITIS (KOA)
Authors: CREAMER P LETHBRIDGECEJKU M HOCHBERG MC ZENG O BOLOGNESE J EHRICH E
Citation: P. Creamer et al., INDIVIDUAL RADIOGRAPHIC FEATURES (IRFS) ARE NOT ASSOCIATED WITH SEVERITY OF PAIN AND PHYSICAL-DISABILITY IN PATIENTS WITH KNEE OSTEOARTHRITIS (KOA), Arthritis and rheumatism, 41(9), 1998, pp. 327-327
MK-0966, A SPECIFIC COX-2 INHIBITOR, HAS CLINICAL EFFICACY COMPARABLETO DICLOFENAC IN THE TREATMENT OF KNEE AND HIP OSTEOARTHRITIS (OA) INA 26-WEEK CONTROLLED CLINICAL-TRIAL
Authors: CANNON G CALDWELL J HOLT P MCLEAN B ZENG Q EHRIC E SEIDENBERG B BOLOGNESE J DANIELS B
Citation: G. Cannon et al., MK-0966, A SPECIFIC COX-2 INHIBITOR, HAS CLINICAL EFFICACY COMPARABLETO DICLOFENAC IN THE TREATMENT OF KNEE AND HIP OSTEOARTHRITIS (OA) INA 26-WEEK CONTROLLED CLINICAL-TRIAL, Arthritis and rheumatism, 41(9), 1998, pp. 983-983
MK-0966, A SPECIFIC COX-2 INHIBITOR, HAS CLINICAL EFFICACY COMPARABLETO IBUPROFEN IN THE TREATMENT OF KNEE AND HIP OSTEOARTHRITIS (OA) IN A 6-WEEK CONTROLLED CLINICAL-TRIAL
Authors: SAAG K FISHER C MCKAY J EHRIC E ZHAO PL BOLOGNESE J SEIDENBERG B DANIELS B
Citation: K. Saag et al., MK-0966, A SPECIFIC COX-2 INHIBITOR, HAS CLINICAL EFFICACY COMPARABLETO IBUPROFEN IN THE TREATMENT OF KNEE AND HIP OSTEOARTHRITIS (OA) IN A 6-WEEK CONTROLLED CLINICAL-TRIAL, Arthritis and rheumatism, 41(9), 1998, pp. 984-984
COMPARISON OF SEVERAL COMPOSITE END-POINTS IN THE ASSESSMENT OF MK-0966 EFFICACY IN RHEUMATOID-ARTHRITIS
Authors: ZENG Q BOLOGNESE J EHRICH E DANIELS B
Citation: Q. Zeng et al., COMPARISON OF SEVERAL COMPOSITE END-POINTS IN THE ASSESSMENT OF MK-0966 EFFICACY IN RHEUMATOID-ARTHRITIS, Arthritis and rheumatism, 41(9), 1998, pp. 1045-1045
A MODEL OF THE HEALTH-EFFECTS OF OSTEOARTHRITIS (OA) OF THE KNEE
Authors: CREAMER P LETHRIDGECEIKY M HOCHBERG MC ZENG O BOLOGNESE J EHRICH E
Citation: P. Creamer et al., A MODEL OF THE HEALTH-EFFECTS OF OSTEOARTHRITIS (OA) OF THE KNEE, Arthritis and rheumatism, 41(9), 1998, pp. 1178-1178
PRECISION OF COMPOSITE MEASURES OF OSTEOARTHRITIS EFFICACY COMPARED WITH THAT OF INDIVIDUAL END-POINTS
Authors: BOLOGNESE J EHRICH E SCHNITZER T ZENG Q
Citation: J. Bolognese et al., PRECISION OF COMPOSITE MEASURES OF OSTEOARTHRITIS EFFICACY COMPARED WITH THAT OF INDIVIDUAL END-POINTS, Arthritis and rheumatism, 41(9), 1998, pp. 1974-1974
SELECTIVE-INHIBITION OF CYCLOOXYGENASE-2 (COX-2) WITH MK-0966 (250 MGQD) IS ASSOCIATED WITH LESS GASTRODUODENAL DAMAGE THAN ASPIRIN (ASA) 650 MG QID OR IBUPROFEN (IBU) 800 MG TID
Authors: LANZA F SIMON T QUAN H BOLOGNESE J RACK MF HOOVER M WILSON F
Citation: F. Lanza et al., SELECTIVE-INHIBITION OF CYCLOOXYGENASE-2 (COX-2) WITH MK-0966 (250 MGQD) IS ASSOCIATED WITH LESS GASTRODUODENAL DAMAGE THAN ASPIRIN (ASA) 650 MG QID OR IBUPROFEN (IBU) 800 MG TID, Gastroenterology, 112(4), 1997, pp. 194-194
MK-966, A HIGHLY SELECTIVE COX-2 INHIBITOR, WAS EFFECTIVE IN THE TREATMENT OF OSTEOARTHRITIS (OA) OF THE KNEE AND HIP IN A 6-WEEK PLACEBO-CONTROLLED STUDY
Authors: EHRICH E SCHNITZER T KIVITZ A WEAVER A WOLFE F MORRISON B ZENG Q BOLOGNESE J SEIDENBERG B
Citation: E. Ehrich et al., MK-966, A HIGHLY SELECTIVE COX-2 INHIBITOR, WAS EFFECTIVE IN THE TREATMENT OF OSTEOARTHRITIS (OA) OF THE KNEE AND HIP IN A 6-WEEK PLACEBO-CONTROLLED STUDY, Arthritis and rheumatism, 40(9), 1997, pp. 330-330
A DIRECT COMPARISON OF THE PRECISION AND SENSITIVITY OF LIKERT AND VISUAL ANALOG RESPONSE SCALES IN A PLACEBO-CONTROLLED STUDY OF PATIENTS WITH OSTEOARTHRITIS OF THE KNEE
Authors: ZENG Q EHRICH E SCHNIZER T BOLOGNESE J
Citation: Q. Zeng et al., A DIRECT COMPARISON OF THE PRECISION AND SENSITIVITY OF LIKERT AND VISUAL ANALOG RESPONSE SCALES IN A PLACEBO-CONTROLLED STUDY OF PATIENTS WITH OSTEOARTHRITIS OF THE KNEE, Arthritis and rheumatism, 40(9), 1997, pp. 1228-1228
ORAL-ADMINISTRATION OF THE GROWTH-HORMONE RELEASING PEPTIDE-MIMETIC MK-677 INCREASES MARKERS OF BONE TURNOVER IN ELDERLY ADULTS
Authors: MURPHY G BACH M PLOTKIN D BOLOGNESE J CERCHIO K GORMLEY G GERTZ B
Citation: G. Murphy et al., ORAL-ADMINISTRATION OF THE GROWTH-HORMONE RELEASING PEPTIDE-MIMETIC MK-677 INCREASES MARKERS OF BONE TURNOVER IN ELDERLY ADULTS, Journal of bone and mineral research, 11, 1996, pp. 668-668
MK-0677, AN ORAL GH SECRETAGOGUE INCREASES SERUM IGF-I IN MUSCULOSKELETALLY IMPAIRED ELDERLY SUBJECTS
Authors: BACH MA PLOTKIN D BOLOGNESE J FARMER M GELATO M KAISER FE KIEL D KORENMAN S MCKEEVER C MUNOZ D SCHWARTZ R GORMLEY GJ
Citation: Ma. Bach et al., MK-0677, AN ORAL GH SECRETAGOGUE INCREASES SERUM IGF-I IN MUSCULOSKELETALLY IMPAIRED ELDERLY SUBJECTS, Journal of the American Geriatrics Society, 44(9), 1996, pp. 37-37
Risultati: 1-12 |